FDA TAKES ON ANTICOMPETITIVE PHARMA PRACTICES
FDA Commissioner Scott Gottlieb Wednesday called on branded drug companies to “end the shenanigans” they use to block generic competition, and announced new steps to rein in some anticompetitive practices.
